1. Home
  2. NPWR vs FATE Comparison

NPWR vs FATE Comparison

Compare NPWR & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NET Power Inc.

NPWR

NET Power Inc.

N/A

Current Price

$0.96

Market Cap

105.3M

Sector

Energy

ML Signal

N/A

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

N/A

Current Price

$2.08

Market Cap

125.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NPWR
FATE
Founded
2010
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.3M
125.6M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
NPWR
FATE
Price
$0.96
$2.08
Analyst Decision
Strong Buy
Buy
Analyst Count
5
11
Target Price
$2.85
★ $5.74
AVG Volume (30 Days)
546.3K
★ 1.2M
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.88
EPS
N/A
★ N/A
Revenue
N/A
★ $6,646,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.87
$0.95
52 Week High
$4.11
$3.23

Technical Indicators

Market Signals
Indicator
NPWR
FATE
Relative Strength Index (RSI) 25.23 44.31
Support Level N/A $1.78
Resistance Level $1.84 $2.15
Average True Range (ATR) 0.07 0.13
MACD -0.01 0.02
Stochastic Oscillator 20.52 60.95

Price Performance

Historical Comparison
NPWR
FATE

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. Its business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. The company has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: